• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home / Exclusive

COVID-19 fight | Baba Ramdev’s Patanjali says Coronil has received certification from Ayush Ministry

The company claimed that it is the first evidence-based medicine to fight COVID-19

  • Press Trust of India
  • Last Updated : February 19, 2021, 14:14 IST
  • Follow
  • Follow

New Delhi: Haridwar-based Patanjali Ayurved on February 19 said Coronil has now received certification from Ayush Ministry as per World Health Organization (WHO) certification scheme.

The company claimed that it is the first evidence-based medicine to fight COVID-19.

The medicine was launched here at an event which was presided by Union Health Minister Harsh Vardhan and Transport Minister Nitin Gadkari.

“Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme,” said Patanjali in a statement.

Under CoPP, Coronil can now be exported to 158 countries.

Commenting of the development Swami Ramdev said, Coronil will help the humanity while providing affordable treatment based on naturopathy.

On the basis of presented data, the Ministry of Ayush has recognised Coronil Tablet as a medicine for “supporting measure in COVID-19.” Patanjali had earlier introduced Ayurveda-based Coronil on June 23 last year, when the pandemic was at its peak.

However, it had to face severe criticism as it lacked scientific evidence.

Then, the Ayush Ministry had indicated it as “Immuno-booster” only.

Coronil is developed by Patanjali Research Institute. It had started work for an Ayurvedic remedy for COVID-19 in January, 2020.

Published: February 19, 2021, 14:14 IST

Download Money9 App for the latest updates on Personal Finance.

  • Ayush Ministry
  • Coronil
  • Covid-19

Related

  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • भारत-रूस समिट में बड़े फैसलों की तैयारी, इकोनॉमिक पार्टनरशिप पर बड़ा फोकस
  • भारत और यूरोपीय संघ के बीच पैसे भेजना होगा आसान,RBI ने शुरू की UPI TIPS; जानें कैसे करेगा काम
  • श्रम संहिता लागू होने से निर्यातकों को मिलेगा प्रोत्साहन: अधिकारी
  • मारुति सुजुकी ने प्रौद्योगिकी स्टार्टअप में करीब आठ प्रतिशत हिस्सेदारी हासिल की
  • टोयोटा ने डैशबोर्ड के हिस्से को बदलने के लिए 11.5 हजार अर्बन क्रूजर हाइडर वापस मंगाईं

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • इंडिगो की 180 से अधिक उड़ानें रद्द
  • भारत-रूस समिट में बड़े फैसलों की तैयारी, इकोनॉमिक पार्टनरशिप पर बड़ा फोकस
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close